Search

Displaying results 5241 - 5250 of 7503 in total
  1. Drug

    ISIS 14803

    go.drugbank.com/drugs/DB05803
    Investigational

    ISIS 14803 is a 20-unit antisense phosphorothioate oligodeoxynucleotide that binds to hepatitis C virus (HCV) RNA at the translation initiation region of the internal ribosome entry site (IRES) and inhibits

  2. Drug

    Lofentanil

    go.drugbank.com/drugs/DB09174
    ExperimentalIllicit

    It displays most similarity to carfentanil (4-carbomethoxyfentanyl) and is considered to be slightly more potent than this drug.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  3. Drug

    Aloe vera flower

    go.drugbank.com/drugs/DB14254
    Approved

    It is not an approved drug.

  4. Drug

    Corydalis ambigua tuber

    go.drugbank.com/drugs/DB14279
    Approved

    It is not an approved drug.

  5. Drug

    Lonicera caprifolium flower

    go.drugbank.com/drugs/DB14280
    Approved

    It is not an approved drug.

  6. Drug

    Larix sibirica wood

    go.drugbank.com/drugs/DB14289
    ApprovedWithdrawn

    It is not an approved drug.

  7. Drug

    Apricot kernel oil

    go.drugbank.com/drugs/DB14324
    Approved

    It is not an approved drug.

  8. Drug

    Azadirachta indica leaf

    go.drugbank.com/drugs/DB14352
    Approved

    It is not an approved drug.

  9. Drug

    GT 389-255

    go.drugbank.com/drugs/DB05894
    Experimental

    It is expected to block fat absorption with fewer side effects than currently marketed lipase inhibitors.

  10. Drug

    Dilmapimod

    go.drugbank.com/drugs/DB12140
    Investigational

    Previous p38 MAP-kinase inhibitors have been hindered in development by liver toxicity. Methotrexate (common treatment for RA patients) also has potential liver toxicity.}